Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Johnson & Johnson, Boston Scientific to Battle Again Over Same Stent Patent - Medical Product Outsourcing

Johnson & Johnson, Boston Scientific to Battle Again Over Same Stent Patent

Johnson & Johnson files new lawsuit over old patent

Years after a jury found Boston Scientific infringed on a Cordis stent patent, the Johnson & Johnson (J&J) unit has filed a new lawsuit over the same patent, alleging that Boston Scientific’s new stent is no different.

The suit, filed in the U.S. District Court for the District of Delaware, comes right after Boston Scientific received FDA approval to market its second-generation Taxus Liberte paclitaxel-eluting coronary stent in the U.S. earlier this month.

Cordis claims the Taxus Liberte, which has no “colorable difference” from the first-generation model, infringes on the company’s Gray patent, which relates to stent architecture and geometry.

SOURCE: FDANEWS

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters